An unfortunate juxtaposition

Por Stone, Jeremy A
Publicado em 2008

Organic dust augments nucleotide-binding oligomerization domain expression via an NF-κB pathway to negatively regulate inflammatory responses

Por Poole, Jill A., Kielian, Tammy, Wyatt, Todd A., Gleason, Angela M., Stone, Jeremy, Palm, Kelsey, West, William W., Romberger, Debra J.
Publicado em 2011

Evidence for the Novel Expression of Human Kallikrein-related Peptidase 3, Prostate-Specific Antigen, in the Brain

Por Stone, Jeremy G., Rolston, Raj K., Ueda, Masumi, Lee, Hyoung-Gon, Richardson, Sandy L., Castellani, Rudy J., Perry, George, Smith, Mark A.
Publicado em 2008

Frontiers in Alzheimer's Disease Therapeutics

Por Stone, Jeremy G., Casadesus, Gemma, Gustaw-Rothenberg, Kasia, Siedlak, Sandra L., Wang, Xinglong, Zhu, Xiongwei, Perry, George, Castellani, Rudy J., Smith, Mark A.
Publicado em 2011

The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated with Tau Pathology in Several Tauopathies

Por Stone, Jeremy G., Siedlak, Sandra L., Tabaton, Massimo, Hirano, Asao, Castellani, Rudy J., Santocanale, Corrado, Perry, George, Smith, Mark A., Zhu, Xiongwei, Lee, Hyoung-gon
Publicado em 2011

Familial genes in sporadic disease: Common variants of α-Synuclein gene associate with Parkinson’s disease

Por Ross, Owen A., Gosal, David, Stone, Jeremy T., Lincoln, Sarah J., Heckman, Michael G., Irvine, Brent G., Johnston, Janet A., Gibson, J. Mark, Farrer, Matthew J., Lynch, Timothy
Publicado em 2007

Dysregulation of Leptin Signaling in Alzheimer Disease: Evidence for Neuronal Leptin Resistance

Por Bonda, David J., Stone, Jeremy G., Torres, Sandy L., Siedlak, Sandra L., Perry, George, Kryscio, Richard, Jicha, Gregory, Casadesus, Gemma, Smith, Mark A., Zhu, Xiongwei, Lee, Hyoung-gon
Publicado em 2013

Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease

Por Ross, Owen A., Haugarvoll, Kristoffer, Stone, Jeremy T., Heckman, Michael G., White, Linda R., Aasly, Jan O., Gibson, J. Mark, Lynch, Timothy, Wszolek, Zbigniew K., Uitti, Ryan J., Farrer, Matthew J.
Publicado no Parkinsonism Relat Disord (2007)

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

Por Bonda, David J., Mailankot, Maneesh, Stone, Jeremy G., Garrett, Matthew R., Staniszewska, Magdalena, Castellani, Rudy J., Siedlak, Sandra L., Zhu, Xiongwei, Lee, Hyoung-gon, Perry, George, Nagaraj, Ram H., Smith, Mark A.
Publicado em 2013

Phactr2 and Parkinson's disease

Por Wider, Christian, Lincoln, Sarah J., Heckman, Michael G., Diehl, Nancy N., Stone, Jeremy T., Haugarvoll, Kristoffer, Aasly, Jan O., Gibson, J. Mark, Lynch, Timothy, Rajput, Alex, Rajput, Michele L., Uitti, Ryan J., Wszolek, Zbigniew K., Farrer, Matthew J., Ross, Owen A.
Publicado em 2009

Genomewide Association, Parkinson Disease, and PARK10

Por Farrer, Matthew J., Haugarvoll, Kristoffer, Ross, Owen A., Stone, Jeremy T., Milkovic, Nicole M., Cobb, Stephanie A., Whittle, Andrew J., Lincoln, Sarah J., Hulihan, Mary M., Heckman, Michael G., White, Linda R., Aasly, Jan O., Gibson, J. Mark, Gosal, David, Lynch, Timothy, Wszolek, Zbigniew K., Uitti, Ryan J., Toft, Mathias
Publicado em 2006